Comment re: "Sporadic Aberrant Crypt Foci Are Not a Surrogate Endpoint for Colorectal Adenoma Prevention" and "Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial"

被引：5
作者：
Stevens, Richard G. [1 ]
Pretlow, Theresa P. [2 ]
Hurlstone, D. Paul [3 ]
Giardina, Charles [4 ]
Rosenberg, Daniel W. [5 ]
机构：
[1] Univ Connecticut, Ctr Hlth, Dept Community Med, Farmington, CT USA
[2] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA
[3] Univ Sheffield, Royal Hallamshire Hosp, Sch Med, Gastroenterol & Liver Unit, Sheffield S10 2JF, S Yorkshire, England
[4] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA
[5] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Colon Canc Prevent Program, Farmington, CT USA
来源：
CANCER PREVENTION RESEARCH | 2008年 / 1卷 / 03期
关键词：
D O I：
10.1158/1940-6207.CAPR-08-0094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：215 / U70
页数：2
相关论文
共 10 条
  • [1] OBSERVATION AND QUANTIFICATION OF ABERRANT CRYPTS IN THE MURINE COLON TREATED WITH A COLON CARCINOGEN - PRELIMINARY FINDINGS
    BIRD, RP
    [J]. CANCER LETTERS, 1987, 37 (02) : 147 - 151
  • [2] Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial
    Cho, Nancy L.
    Redston, Mark
    Zauber, Ann G.
    Carothers, Adelaide M.
    Hornick, Jason
    Wilton, Andrew
    Sontag, Stephen
    Nishioka, Norman
    Giardiello, Francis M.
    Saltzman, John R.
    Gostout, Chris
    Eagle, Craig J.
    Hawk, Ernest T.
    Bertagnolli, Monica M.
    [J]. CANCER PREVENTION RESEARCH, 2008, 1 (01) : 21 - 31
  • [3] How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men
    Corpet, DE
    Pierre, F
    [J]. EUROPEAN JOURNAL OF CANCER, 2005, 41 (13) : 1911 - 1922
  • [4] Aberrant crypt foci: What we know and what we need to know
    Gupta, Akshay K.
    Pretlow, Theresa P.
    Schoen, Robert E.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (05) : 526 - 533
  • [5] Sporadic Aberrant Crypt Foci Are Not a Surrogate Endpoint for Colorectal Adenoma Prevention
    Lance, Peter
    Hamilton, Stanley R.
    [J]. CANCER PREVENTION RESEARCH, 2008, 1 (01) : 4 - 8
  • [6] PRETLOW TP, 1991, CANCER RES, V51, P1564
  • [7] Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans
    Rosenberg, Daniel W.
    Yang, Shi
    Pleau, Devon C.
    Greenspan, Emily J.
    Stevens, Richard G.
    Rajan, Thiruchandurai V.
    Heinen, Christopher D.
    Levine, Joel
    Zhou, Yijian
    O'Brien, Michael J.
    [J]. CANCER RESEARCH, 2007, 67 (08) : 3551 - 3554
  • [8] Siu IM, 1999, CANCER RES, V59, P63
  • [9] Epidemiology of colonic aberrant crypt foci: Review and analysis of existing studies
    Stevens, Richard G.
    Swede, Helen
    Rosenberg, Daniel W.
    [J]. CANCER LETTERS, 2007, 252 (02) : 171 - 183
  • [10] Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer
    Suzuki, H
    Watkins, DN
    Jair, KW
    Schuebel, KE
    Markowitz, SD
    Chen, WD
    Pretlow, TP
    Bin Yang,
    Akiyama, Y
    van Engeland, M
    Toyota, M
    Tokino, T
    Hinoda, Y
    Imai, K
    Herman, JG
    Baylin, SB
    [J]. NATURE GENETICS, 2004, 36 (04) : 417 - 422
1